They have several different binding sites that simultaneously bind to the T cell receptor (TCR) CD3ε subunit on T cells and surface molecules on targeted tumor cells and recruit T cells to mediate cytotoxicity against tumor cells and creating the immunological synapse [22, 26, 27]. Here, CD3E is linked to neoplasm.